Teva Pharmaceutical Industries Ltd. — Board/Management Information 2012

Jan 2, 2012

_________ false

C002��� ������ ��������� ��"�2PublicTEVA- PHARMACEUTICAL INDUSTRIES LTD.7217Corporation no: 520013954Stock Exchange/Market: ���310380P.O.B 3190 , Petach Tikva 49131 , ,Tel: 03-9267267 , 03-9267652 Fax: 03-9267519E.mail address: elana.holzman@teva.co.ilDate of transmission: 02/01/2012              Time of broadcast: 05:56 05:34:58

Reference: 2012-02-002298

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on TEVA ANNOUNCES MANAGEMENT SUCCESSION Dr. Jeremy Levin, A Former Senior Executive at Bristol-Myers Squibb, To Succeed Shlomo Yanai as President and CEO
SYJLpressrelease010112final_isa.pdf

Please find attached a press release and its non binding Hebrew translation, provided for convenience purposes only.
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
Date of revision of form structure: 29/12/2011
- - -
Name of the Signatory: : Desheh Eyal , Position of Signatory in the reporting corporation: Chief Financial Officer , Name of Employer Company: .
Basel Telephone: 02-9411717 , Facsimile: 02-9411718 , E-mail: elana.holzman@teva.co.il 2